Biocure Technology (XCNQ:CURE.X) FCF Yield % : 2.89 (As of Sep. 23, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Biocure Technology's Trailing 12-Month Free Cash Flow is C$0.07 Mil, and Market Cap is C$2.35 Mil. Therefore, Biocure Technology's FCF Yield % for today is 2.89%.

The historical rank and industry rank for Biocure Technology's FCF Yield % or its related term are showing as below:

XCNQ:CURE.X' s FCF Yield % Range Over the Past 10 Years
Min: -734.29 Med: -24.09 Max: 2.89
Current: 2.89

During the past 13 years, the highest FCF Yield % of Biocure Technology was 2.89%. The lowest was -734.29%. And the median was -24.09%.

XCNQ:CURE.X's FCF Yield % is ranked better than
93.42% of 1534 companies
in the Biotechnology industry
Industry Median: -13.295 vs XCNQ:CURE.X: 2.89

Biocure Technology's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Biocure Technology FCF Yield % Historical Data

The historical data trend for Biocure Technology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocure Technology FCF Yield % Chart

Biocure Technology Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-17.49

-4.78

-7.84

-75.10

-15.39

Biocure Technology Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
FCF Yield %	Get a 7-Day Free Trial															-1.96	-1.96	14.18	-0.28	7.09

Competitive Comparison of Biocure Technology's FCF Yield %

For the Biotechnology subindustry, Biocure Technology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocure Technology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocure Technology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Biocure Technology's FCF Yield % falls into.

Biocure Technology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Biocure Technology's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.217	/	1.4100075
	=	-15.39%

Biocure Technology's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.025	*	4	/	1.4100075
	=	7.09%

Biocure Technology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Biocure Technology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Biocure Technology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocure Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE.X) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.biocuretech.com

Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five majorly biosimilar products in South Korea, including Interferon Beta 1b, PEGFilgrastim, and Ranibizumab as well as CAR-T Cell Therapy. Interferon Beta 1b is used for treating relapsing forms of multiple sclerosis Filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by bone marrow transplants, chemotherapy, and other conditions. Ranibizumab is used for treating macular degeneration. It is also used to treat a type of eye problem known as macular edema, as well as certain eye problems caused by diabetes.

Executives

Konstantin Lichtenwald

Director, Senior Officer

Biocure Technology Headlines

No Headlines